|
CNBC'S MOST SHARED
- Unemployed? Bored? Make Money Playing Beer Pong
- Social Networking's 'Naked' Truth
- The Highest Grossing (Inflation Adjusted) Movies of All Time
- WPP's Sir Martin Sorrell on the Ad Recession
- Geek Squad V. Gizmodo
- Merrill's McCann Seen as UBS Wealth Frontrunner
- Warren Buffett's Top Three Investment Rules for the Average American
- Why You Should Watch Fund Flows
- Blog You!!!
- Stimulus Will Kick in Later this Year: President Obama
- Lender CIT Group Hires Premier Bankruptcy Adviser
- Government Selling Bank Stakes for Too Cheap: Panel
- Buffett's Top 3 Investment Rules for Average Americans
- Market Insider: Earnings Loom in the Week Ahead
- Bulls Get Summertime Blues, But It's Hot Fun for Bears
- As Banks Fail, Strong Institutions Become More Visible
- GM IPO in Second Quarter 2010 at the Earliest: CFO
- Merrill's McCann Seen as UBS Wealth Frontrunner
- Eric Schmidt on Government Scrutiny and Economic Recovery
- Market 360: The Week's Best & Worst
- Geek Squad V. Gizmodo
- Brandt: Google Chrome OS in the Post-PC Age
- Other People Are Weirder Than We Are
- Bank Failures: Is The Nightmare Over? (Video)
- California Here I Go? No.
- Roginsky: No More Mr. Nice Guy
- Commercial Conundrum
Text Size 
Analyst actions and clinical trial data were some of the catalysts behind the most actively traded stocks on Wednesday.
Shares of Bristol-Myers Squibb [BMY
Loading...
()
] rose after Citigroup upgraded the stock to "buy" from "hold" and said Wall Street is underestimating the company's ability to widen profit margins.
In addition, analyst George Grofik said consensus margin forecasts -- well below the industry average -- leave room for improvement as Plavix sales continue to grow. And while a potential takeover of Bristol has a low probability of happening, the analyst said, a deal would warrant a takeout price of about $35 to $40 a share.
"In light of recent weakness, we believe Bristol-Myers shares represent a compelling risk-reward proposition," said Grofik.
Ford Motor [MDVN
Loading...
()
] shares rose on news the automaker was selling its Jaguar and Land Rover brands. The Dearborn, Mich.-based company has suggested in the past that it would consider selling the two British brands, and on Tuesday said it was reviewing its position on them.
Network equipment maker Finisar [FNSR
Loading...
()
] reaffirmed its first-quarter revenue forecast on Tuesday after the close of trading, sending shares higher Wednesday. The company said during a conference call with analysts that it expects revenue of $105 million to $112 million in the first quarter. Analysts expect the Sunnyvale, Calif.-based company to post revenue of $107.3 million.
Lawson Software [LWSN
Loading...
()
] gained 7% on Wednesday after the business application software maker raised forecasts for the fourth quarter. Lawson raised its quarterly earnings estimate by 2 cents a share and raised revenue guidance above Wall Street expectations.
Among downside movers, HealthSpring [HS
Loading...
()
] fell on heavy trading volume after the managed healthcare provider cut 2007 earnings estimates, citing higher-than-expected medical service costs and facility charges.
Print
Email
Data is a real-time snapshot *Data is delayed at least 15 minutes